Human epidermal growth factor receptor 2-subtype invasive ductal carcinoma recurring as basal-human epidermal growth factor receptor 2-subtype squamous cell carcinoma

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Squamous cell carcinoma of the breast and its subtype, basal-human epidermal growth factor receptor 2 (HER2) phenotype, are very rare. Herein, we report a patient who developed recurrence of squamous cell carcinoma of the breast with basal-HER2 subtype 6 years after the initial diagnosis of invasive ductal carcinoma of the HER2 subtype. To the best of our knowledge, recurrence of invasive ductal carcinoma in the form of metaplastic squamous cell carcinoma of basal-HER2 subtype has not been reported previously. We present a pathological perspective of our experience.

Cite

CITATION STYLE

APA

An, J., Yoo, Y., Kim, H. G., Woo, J., Lee, K. E., Kwon, H., … Moon, B. I. (2019). Human epidermal growth factor receptor 2-subtype invasive ductal carcinoma recurring as basal-human epidermal growth factor receptor 2-subtype squamous cell carcinoma. Journal of Breast Cancer, 22(3), 484–490. https://doi.org/10.4048/jbc.2019.22.e31

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free